Entertainment gossip and news from Newsweek’s network of contributors
In a move that blurs the line between science fiction and reality, Colossal Biosciences, the pioneering de-extinction company backed by countless celebs, has secured $200 million in Series C funding. This brings their total investment to nearly half a billion dollars since their inception in 2021, solidifying their position at the forefront of a revolutionary field.
Co-founded by geneticist George Church and billionaire tech entrepreneur Ben Lamm, Colossal has achieved “decacorn” status in just three years, boasting a valuation exceeding $10 billion. This rise places them among an elite group of startups worldwide and shows the growing interest in the once-fantastical concept of de-extinction.
The company’s ambitious goal is to resurrect extinct species like the woolly mammoth, the dodo, and the Tasmanian tiger. By leveraging cutting-edge genetic engineering …